Jun 04, 2019
Harmony Biosciences To Present New Data On Pitolisant In Patients With Narcolepsy At SLEEP 2019 Meeting
May 29, 2019
Lannett Commences Marketing Generic Concerta®
May 26, 2019
Lebanon arrests Saudi at airport with 10 kg of captagon drug
Apr 30, 2019
Lannett To Launch Generic Concerta®, AB-rated Methylphenidate Hydrochloride ER Tablets
Apr 29, 2019
Harmony Biosciences To Present Data On Pitolisant In Patients With Narcolepsy At 2019 American Academy Of Neurology Meeting
Apr 10, 2019
Drugs of Abuse Testing: Technologies and Global Markets
Mar 27, 2019
ANI Pharmaceuticals Announces Two Generic Product Launches
Feb 18, 2019
Confirm BioSciences At-Home Drug Detection Tool HairConfirm® to Roll Out at Major National Retailers Starting February 2019
Feb 11, 2019
ADHD Market Size Worth $24.9 Billion by 2025 | CAGR: 6.4%: Grand View Research, Inc.
Jan 29, 2019
Cognitive and Memory Enhancer Drugs Market to Garner $6.59 Bn, Globally, by 2023 at 8.6% CAGR, Says AMR
Jan 17, 2019
Tris Pharma to Present Three Posters Covering Data on Dyanavel® XR and Tris' LiquiXR® Technology at the 2019 APSARD Annual Meeting
Dec 21, 2018
Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
Dec 19, 2018
Workforce Drug Positivity Rises by Double-Digits in Almost One-Third of U.S. Industry Sectors Examined, According to New Quest Diagnostics Analysis
Nov 12, 2018
Tris Pharma Presents Clinical Data for DYANAVEL® XR (amphetamine) at the 2018 Neuroscience Education Institute (NEI) Congress
Nov 08, 2018
White House ONDCP Deputy Director James Carroll to Address Attendees at Healthcare Made Practical's Inaugural National Cocaine, Meth, & Stimulant Summit
Nov 01, 2018
DURECT Corporation Invites You to Join its Third Quarter 2018 Earnings Conference Call
Oct 07, 2018
American DJ David Morales arrested in Japan for ecstasy possession
Sep 27, 2018
Data On Abuse Potential Of Pitolisant Presented At 2018 European Sleep (ESRS) Congress
Sep 25, 2018
Tris Pharma Expands ADHD Portfolio with Acquisition of NextWave Pharmaceuticals
Jul 25, 2018
Bioprojet and Endo Jointly Announce Agreement for Paladin Labs Inc. to Commercialize Pitolisant in Canada